Overview
Details
Chat
Zai Lab Ltd. Sponsored ADR (ZLAB.US/09688.HK) Q1 2022 Earnings Conference Call
Live streaming time: 11/05/2022 19:08
ZaiLab Ltd. is a biopharmaceutical company committed to developing and commercializing therapeutic methods to address unmet medical needs in oncology, autoimmune diseases, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.
Risk and Disclaimer Statement:
The content on this page reflects the personal opinion of the author and is intended solely as general information for your reference. It shall not be construed as advice or a basis for any specific investment, business, or commercial decisions. The views expressed in the content do not represent any position of LongPort or any investment recommendations or endorsements related to LongPort. LongPort does not make any guarantee or commitment to the truthfulness, accuracy, or originality of the content. Investors should analyze the risks related to the investment based on their own circumstances and seek advice from a professional investment advisor when necessary.